InsiderTrades

Form 4 for OLMA Olema Pharmaceuticals, Inc.

Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-10 · accession 0001415889-21-005174 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-11-12 2021-11-10 OLMA Horn Kinney Chief BUSINESS Off M - OptEx $15.79 +27.7K 29.5K +1,546% +$436.7K
D 2021-11-12 2021-11-10 OLMA Horn Kinney Chief BUSINESS Off S - Sale+OE $26.88 -27.7K 1,790 -94% -$743.7K
DM 2021-11-12 2021-11-10 OLMA Horn Kinney Chief BUSINESS Off M - OptEx $0.00 -27.7K 162.8K -15% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-10 M A 5,251 $2.06 7,041 D — —
2 Common Common Stock 2021-11-10 S D 27,668 $26.88 1,790 D — — (F2) T he weighted average sale price for the transaction reported was $26.88, and the range of prices was between $26.56 and $27.32. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
3 Common Common Stock 2021-11-10 M A 22,417 $19.00 29,458 D — —
4 Derivative Stock Option (Right to Buy) 2021-11-10 M D 22,417 $0.00 67,253 D $19.00 · — to 2030-11-09 22,417 Common Stock (F4) One thirty-sixth of the remaining number of shares subject to the option vest on a monthly basis, subject to the Reporting Person's continuous service through each applicable vesting date.
5 Derivative Stock Option (Right to Buy) 2021-11-10 M D 5,251 $0.00 162,791 D $2.06 · — to 2030-06-09 5,251 Common Stock (F3) The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.